Picture of Steris logo

STE Steris News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

REG-BARCLAYS PLC Form 8.3 - STERIS CORPORATION <Origin Href="QuoteRef">BARC.L</Origin> <Origin Href="QuoteRef">STE.N</Origin>

Form 8.3 - STERIS CORPORATION

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the Code)

1. KEY INFORMATION

(a) Full name of discloser: Barclays PLC.
(b) Owner or controller of interest and short
positions disclosed, if different from 1(a):
(c) Name of offeror/offeree in relation to whose STERIS CORPORATION
relevant securities this form relates:
(d) If an exempt fund manager connected with an
offeror/offeree, state this and specify identity of
offeror/offeree:
(e) Date position held/dealing undertaken: 13 October 2015
(f) In addition to the company in 1(c) above, is the discloser making YES:
disclosures in respect of any other party to the offer? SYNERGY HEALTH PLC

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: ORD
Interests Short Positions
Number (%) Number (%)
(1) Relevant securities owned
and/or controlled: 2,904 0.00% 286,611 0.48%
(2) Cash-settled derivatives:
284,112 0.47% 0 0.00%
(3) Stock-settled derivatives (including options)
and agreements to purchase/sell: 0 0.00% 0 0.00%
(4)
TOTAL: 287,016 0.48% 286,611 0.48%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form8 (Open Positions).

(b) Rights to subscribe for new securities (including directors and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant Purchase/sale Number of Price per unit
security securities
ORD Purchase 1 66.9700 USD
ORD Purchase 23 67.0000 USD
ORD Purchase 56 67.0300 USD
ORD Purchase 100 66.2100 USD
ORD Purchase 100 66.3899 USD
ORD Purchase 180 66.3400 USD
ORD Purchase 200 66.5650 USD
ORD Purchase 208 66.3094 USD
ORD Purchase 213 66.3759 USD
ORD Purchase 215 66.3316 USD
ORD Purchase 300 66.8310 USD
ORD Purchase 355 66.3588 USD
ORD Purchase 500 66.7948 USD
ORD Purchase 503 66.5721 USD
ORD Purchase 587 66.3189 USD
ORD Purchase 675 66.3244 USD
ORD Purchase 697 67.0097 USD
ORD Purchase 797 66.5900 USD
ORD Purchase 1,500 67.2457 USD
ORD Purchase 2,100 67.1110 USD
ORD Purchase 3,929 67.0920 USD
ORD Sale 79 67.0212 USD
ORD Sale 100 66.2100 USD
ORD Sale 100 66.7600 USD
ORD Sale 100 66.5500 USD
ORD Sale 198 67.1351 USD
ORD Sale 200 67.2050 USD
ORD Sale 200 67.0400 USD
ORD Sale 278 66.8830 USD
ORD Sale 299 67.0771 USD
ORD Sale 300 66.7180 USD
ORD Sale 600 67.0675 USD
ORD Sale 673 66.9358 USD
ORD Sale 700 67.0465 USD
ORD Sale 1,200 67.2311 USD
ORD Sale 1,282 67.1749 USD
ORD Sale 1,400 67.1433 USD
ORD Sale 1,496 67.1150 USD
ORD Sale 1,500 66.5806 USD
ORD Sale 2,533 66.3353 USD

(b) Cash-settled derivative transactions

Class of relevant security Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities Price per unit

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.

Expiry date Option money paid/ received per unit

(ii) Exercise

Class of relevant security Product description

e.g. call option

Exercising/ exercised against Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion

Details Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding,
formal or informal, relating to relevant securities which may be an inducement to deal
or refrain from dealing entered into by the person making the disclosure and any party
to the offer or any person acting in concert with a party to the offer:
NONE

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between
the person making the disclosure and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights of future acquisition or disposal of any relevant securities to which
any derivative is referenced:
NONE

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 14 Oct 2015
Contact name: Jay Supaya
Telephone number: 020 7773 0635

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panels Market Surveillance Unit is available for consultation in relation to the Codes disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panels website at www.thetakeoverpanel.org.uk.

BARCLAYS PLC

Recent news on Steris

See all news